OceanBase Receives Honorable Mention for the Second Consecutive Year in the 2024 Gartner® Magic Quadrant™ Report

OceanBase Receives Honorable Mention for the Second Consecutive Year in the 2024 Gartner® Magic Quadrant™ Report

SINGAPORE, Dec. 26, 2024 /PRNewswire/ -- OceanBase has once again been named as Honorable Mention in the 2024 Gartner® Magic Quadrant™ for Cloud Database Management Systems (Cloud DBMS), marking the second consecutive year it has received this...

Mowilex, Indonesia's First Carbon Neutral Manufacturer, Receives CarbonNeutral® Company Certification for the Sixth Consecutive Year

Mowilex, Indonesia's First Carbon Neutral Manufacturer, Receives CarbonNeutral® Company Certification for the Sixth Consecutive Year

Mowilex has earned its sixth consecutive CarbonNeutral® company certification through investments in innovative technologies and offset programs. The company's environmental commitments are helping Indonesia reach carbon reduction targets while also...

Steelhead LNG Initiates New Legal Proceedings Against Cedar LNG in British Columbia; Receives Three New United States Patents

Steelhead LNG Initiates New Legal Proceedings Against Cedar LNG in British Columbia; Receives Three New United States Patents

VANCOUVER, BC, Dec. 24, 2024 /PRNewswire/ -- Steelhead LNG, a Vancouver-based developer in the liquefied natural gas (LNG) industry, today announced the filing of new legal proceedings against Cedar LNG, Pembina Pipeline Corporation and ARC...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

Smartkem Receives £900,000 Grant from Innovate UK for Advanced MicroLED Displays

Smartkem Receives £900,000 Grant from Innovate UK for Advanced MicroLED Displays

Project in partnership with AUO starts on January 1, 2025 MANCHESTER, England, Dec. 18, 2024 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics using its disruptive organic thin-film transistors (OTFTs), has...

Sinopec Receives ISO's Approval for China's First ISO International Technical Specification for Heavy Oil Development

Sinopec Receives ISO's Approval for China's First ISO International Technical Specification for Heavy Oil Development

BEIJING, Dec. 12, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation's (HKG: 0386, "Sinopec") has successfully obtained ISO's approval for the Technical Specifications for Multi-element Thermal Composite Flooding of Heavy Oil (the...

Rossell Techsys Limited Receives Outstanding Supplier Recognition from Lockheed Martin at the 10th Lockheed Martin Suppliers Conference

Rossell Techsys Limited Receives Outstanding Supplier Recognition from Lockheed Martin at the 10th Lockheed Martin Suppliers Conference

BANGALORE, India, Dec. 11, 2024 /PRNewswire/ -- Rossell Techsys Limited (ROSSTECH), a leading aerospace and defense service provider, has been awarded the prestigious 'Outstanding Supplier Recognition' by Lockheed Martin at the 10th Lockheed Martin...

Aspen Digital receives Financial Services Permission in ADGM to provide services in digital assets

Aspen Digital receives Financial Services Permission in ADGM to provide services in digital assets

The Private Wealth Management Platform has established its financial services business, headquartered in Abu Dhabi, to service the family office and UHNW sector, allocating into digital assets. Aspen Digital provides a one-stop solution for a full...

Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Skyhawk Therapeutics Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's Disease Patient Trial

Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI measurement is also approved as exploratory study endpoint BOSTON,...

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient...

  • 1
  • 2
  • menu
    menu